Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

PET and EBV DNA-directed Therapy for Localized Nasal Extranodal NK/T Cell Lymphoma — Stella

Home/NK-T-Cell Lymphoma, Extranodal/PET and EBV DNA-directed Therapy for Localized Nasal Extranodal NK/T Cell Lymphoma

View on ClinicalTrials.gov

Recruiting

Back to NK-T-Cell Lymphoma, Extranodal trials

PET and EBV DNA-directed Therapy for Localized Nasal Extranodal NK/T Cell Lymphoma

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

Ruijin Hospital, Shanghai, Shanghai Municipality

Key details

Sponsor

Ruijin Hospital

Enrollment target

~89 participants

Started

December 2023

Primary completion

October 2026

Age range

18 Years and older

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.